about
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney diseaseLong-term prognosis after acute kidney injury (AKI): what is the role of baseline kidney function and recovery? A systematic reviewApproaches to ascertaining comorbidity information: validation of routine hospital episode data with clinician-based case note reviewCharlson index scores from administrative data and case-note review compared favourably in a renal disease cohort.Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality.Is routine hospital episode data sufficient for identifying individuals with chronic kidney disease? A comparison study with laboratory data.Maximising Acute Kidney Injury Alerts--A Cross-Sectional Comparison with the Clinical Diagnosis.Acute kidney injury-how does automated detection perform?Acute kidney injury as an independent risk factor for unplanned 90-day hospital readmissions.Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysisKDIGO-based acute kidney injury criteria operate differently in hospitals and the community-findings from a large population cohort.Long term effects of gestational hypertension and pre-eclampsia on kidney function: Record linkage study.Intermediate and Long-term Outcomes of Survivors of Acute Kidney Injury Episodes: A Large Population-Based Cohort Study.Translating chronic kidney disease epidemiology into patient care--the individual/public health risk paradox.Looking to the future: predicting renal replacement outcomes in a large community cohort with chronic kidney disease.Chronic kidney disease, a useful trigger for proactive primary care? Mortality results from a large U.K. cohort.Post-discharge kidney function is associated with subsequent ten-year renal progression risk among survivors of acute kidney injury.Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts.Definitions of progression in chronic kidney disease--predictors and relationship to renal replacement therapy in a population cohort with a 6 year follow-up.Multiple-frequency bioimpedance devices for fluid management in people with chronic kidney disease receiving dialysis: a systematic review and economic evaluation.Models of care for chronic kidney disease: a systematic review.Predicting timing of clinical outcomes in patients with chronic kidney disease and severely decreased glomerular filtration rate.Hip fracture incidence and mortality in chronic kidney disease: the GLOMMS-II record linkage cohort study.Predicting kidney failure risk after acute kidney injury among people receiving nephrology clinic careAcute kidney injury in the UK: a replication cohort study of the variation across three regional populations
P50
Q24235834-25818414-D829-4181-85C6-C852FAF0FD39Q28652412-A1858BB1-1754-40FA-AF23-F0DB42ACE9A1Q30805612-5D8A057A-DF94-4A70-88EB-3C1A7C974124Q30884252-ABB399A3-1FCA-4546-B2FC-E38C0FD13962Q34231098-517646E6-6209-424E-A930-2113AE521CC1Q35536667-8D1796BA-E1C8-4787-B498-BCA14F1752FEQ35678506-5A0E036A-2723-4C64-B072-666923B06924Q36197727-97D7ED91-B354-4347-AB1F-344B3271DA89Q36243268-34F59839-0FA6-4DFE-B3DB-2207680C90AFQ36575996-31A2744C-5C13-410A-A060-E2CF458B530CQ36926940-33FEEA69-71CF-4CC7-813D-32DDB5DAB1F0Q37509879-47F91B0C-6C01-4E81-9784-51B22DACE39BQ37524488-6BC406FD-64EA-46FA-B3FC-BE552668425DQ38005372-AA3AFD1F-5BA8-4B74-B657-3EE7E9453C1EQ39010634-A8CB7F0B-78ED-495D-BE53-EC4A7D3392D5Q39501799-AFD6EABF-8D2F-4E23-BA45-791C780B7E4CQ40239694-7444FE83-59AC-4036-8000-031873333308Q41931102-E2EF0A82-3808-4AE8-A8A6-6F174EE094A3Q44608520-E536FF5B-1BB2-499C-B366-FEF4E0D82D59Q47180716-5BA9F7C7-259B-4ECA-8D1F-AFFADDD22BD3Q47436228-1439E6FD-1D49-4A35-8839-BED0CDE0DE56Q52381850-56DEFC13-7A4A-4C77-BDB9-1379E1463CFDQ53830343-697C6BE0-A548-430F-A280-BC6BB0B56190Q57464881-93AE5E86-08A7-40A8-9C04-76EB49779619Q64123963-89554842-0445-413C-B272-8DDA7DA16123
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Angharad Marks
@ast
Angharad Marks
@en
Angharad Marks
@es
Angharad Marks
@nl
type
label
Angharad Marks
@ast
Angharad Marks
@en
Angharad Marks
@es
Angharad Marks
@nl
prefLabel
Angharad Marks
@ast
Angharad Marks
@en
Angharad Marks
@es
Angharad Marks
@nl
P106
P1153
51763943100
P31
P496
0000-0003-1910-462X